Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Steroidal "ante drugs" from Affymax have potent activity in the lungs, short half-life in plasma

Aug. 24, 1999

Novel VLA-4 antagonists prepared and evaluated at Novartis

Aug. 24, 1999

Neurokinin receptors with broad potential utility discovered at Schering-Plough

Aug. 20, 1999

SRL-172 shows promising initial results in phase I/II asthma trial

Aug. 20, 1999

Discovery receives Cystic Fibrosis Foundation grant for SuperVent

Aug. 20, 1999

Cell adhesion inhibitor series has potential application in inflammatory and immune disorders

Aug. 18, 1999

Immune Network Research forms JV with Bridge Pharma to develop asthma drug

Aug. 18, 1999

Antiinflammatory effects of TxA2 antagonist confirmed in patients with asthma

Aug. 13, 1999

Dual-action antihistamines/substance P antagonists from HMR

Aug. 12, 1999

Bayer will begin clinical trials of IL-4 antagonist for asthma

Aug. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...